Healthcare · Drug Manufacturers—Specialty & Generic
$0.32
+$0.02+7.36%
Delayed · · marketstack
+$0.11+53.82%over 1M
Price ÷ trailing earnings
Revenue grew +19.93% in FY2027, +11.06% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.
No comments yet
Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.
Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.
Updated · the last close
What COSM has filed with the SEC. This is not Cosmos Health Inc.’s own investor relations site: these filings are the primary source that site publishes from.
Also filed under Drug Manufacturers, ranked by how closely they sit beside COSM.
The assistant answers from what COSM has actually filed: 18 annual reports filed with the SEC. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Press one and the answer appears right here on the page, from COSM's filings and figures. One a day without an account; a free account has its own, and no card.
See how much of Cosmos Health Inc. each of these investors holds, and every quarter they moved.
Ten seconds. No card. Nothing to cancel.
Be told the moment a COSM insider trades
Put Cosmos Health Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Cosmos Health Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Cosmos Health Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.
Free, no card, and it does not expire.
Out of 26 passages in this year’s Item 1A.
New this year
4 more passages are on Bespoke
Free, no card, and it does not expire. See what the paid plans add
From Item 1A of its most recent 10-K, filed April 2026.
And 9 more.
FDA approval
Product candidates can and do fail at any stage of the process, including as the result of unfavorable pre-clinical and clinical trial results, or unfavorable new pre-clinical or clinical data and further analyses of existing pre-clinical or clinical data, …7 more themes are on Measure
Free, no card, and it does not expire. See what the paid plans add
21 more events are on Measure
Free, no card, and it does not expire. See what the paid plans add